These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 22496125)
1. Femoral artery percutaneous revascularization for patients with critical limb ischemia: outcomes compared to patients with claudication over 2.5 years. Todoran TM; Connors G; Engelson BA; Sobieszczyk PS; Eisenhauer AC; Kinlay S Vasc Med; 2012 Jun; 17(3):138-44. PubMed ID: 22496125 [TBL] [Abstract][Full Text] [Related]
2. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. DeRubertis BG; Faries PL; McKinsey JF; Chaer RA; Pierce M; Karwowski J; Weinberg A; Nowygrod R; Morrissey NJ; Bush HL; Kent KC Ann Surg; 2007 Sep; 246(3):415-22; discussion 422-4. PubMed ID: 17717445 [TBL] [Abstract][Full Text] [Related]
3. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease. Kalbaugh CA; Taylor SM; Blackhurst DW; Dellinger MB; Trent EA; Youkey JR J Vasc Surg; 2006 Aug; 44(2):296-302; discussion 302-3. PubMed ID: 16814976 [TBL] [Abstract][Full Text] [Related]
4. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score. Ihnat DM; Duong ST; Taylor ZC; Leon LR; Mills JL; Goshima KR; Echeverri JA; Arslan B J Vasc Surg; 2008 May; 47(5):967-74. PubMed ID: 18372147 [TBL] [Abstract][Full Text] [Related]
5. Factors Affecting the Results of Superficial Femoral Artery Stenting. Kay M; Rogoveanu R; Hodson J; Tallowin S; Hopkins J; Duddy M; Vohra R Vasc Endovascular Surg; 2015 Nov; 49(8):228-35. PubMed ID: 26584581 [TBL] [Abstract][Full Text] [Related]
6. Influence of Preprocedural Statin Usage on Primary Patency and Amputation in Patients Undergoing Lower Limb Peripheral Angioplasty. Braun SK; Jorge DW; Pedron VF Ann Vasc Surg; 2024 Sep; 106():213-226. PubMed ID: 38821472 [TBL] [Abstract][Full Text] [Related]
7. Subintimal angioplasty of chronic total occlusion in iliac arteries: a safe and durable option. Chen BL; Holt HR; Day JD; Stout CL; Stokes GK; Panneton JM J Vasc Surg; 2011 Feb; 53(2):367-73. PubMed ID: 21030201 [TBL] [Abstract][Full Text] [Related]
8. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease. Tran K; Ullery BW; Kret MR; Lee JT Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688 [TBL] [Abstract][Full Text] [Related]
9. Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease. Lo RC; Bensley RP; Dahlberg SE; Matyal R; Hamdan AD; Wyers M; Chaikof EL; Schermerhorn ML J Vasc Surg; 2014 Feb; 59(2):409-418.e3. PubMed ID: 24080134 [TBL] [Abstract][Full Text] [Related]
10. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. Conrad MF; Kang J; Cambria RP; Brewster DC; Watkins MT; Kwolek CJ; LaMuraglia GM J Vasc Surg; 2009 Oct; 50(4):799-805.e4. PubMed ID: 19786239 [TBL] [Abstract][Full Text] [Related]